Amid these soaring cases, particularly in underserved and remote communities in the Prairies, the Multiplo® TP/HIV rapid self-test and non-professional tests provides a 'missing key' to help reach the ...
HALIFAX, NS / ACCESS Newswire / January 21, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received Investigational Testing Authorizations (ITAs) from Health Canada to begin clin ...
was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global study among cisgender ... July 22, 2024 — Scientists have ...
Long-term follow-up of the second and third studies found that the injectable treatments (both monthly or every two months) remained effective after three years. The latest news and research on ...
A decade-long study has shed light on the risks of hepatitis D virus superinfection in people with HIV co-infected with ...
MANCHESTER CITY are lining up a stunning January move to re-sign Douglas Luiz, according to reports. Pep Guardiola is planning a mid-season squad overhaul to save City's troubling campaign and ...
NCAA. Ryan Day family: All about his wife Nina and the children of the Ohio State coach who were victims of recent death threats NCAA. Pat McAfee backs Ohio State to win the National Championship ...
Gilead Sciences has the data it was hoping for in a pivotal trial of lenacapavir, an HIV drug that only needs ... to sharing data from longer-term follow-up of CAPELLA study participants next ...
City began proceedings down in eighth place in need of a three-goal margin to move up into the top four, luckily for Pep Guardiola, Phil Foden was on hand to provide the basis to ensure they were ...
HIV infections (human immunodeficiency virus infections) include the spectrum of infections caused by the virus HIV that range from asymptomatic seropositivity to acquired immunodeficiency ...
NPR Ethel Weld, an assistant professor of medicine at the Johns Hopkins University School of Medicine, describes the results from the PURPOSE 1 and PURPOSE 2 trials as "a thrilling game changer for ...
NPR's Up First is the news you need to start your day. The three biggest stories of the day, with reporting and analysis from NPR News — in 10 minutes. Available weekdays at 6:30 a.m. ET ...